At a glance
Read the record in context
Hexarelin's endocrine citation, research-only status, and catalog vial each serve a different purpose. The 0.92-hour model is not a product approval. Likewise, the supplier's 5 mg quantity is not an amount established by the pharmacology publication for a personal plan.[1]
What the research says
The human hexarelin study examined growth hormone release in twelve healthy male volunteers. Each received rising intravenous bolus exposures and placebo in a controlled design. Investigators measured plasma growth hormone concentrations over time, using peak response and the area under its curve as primary pharmacodynamic measures.[2]
Growth hormone peaked at about 30 minutes and returned toward baseline within four hours. The abstract reports an approximately 55-minute half-life for that hormone response. This is a measurement of growth hormone after hexarelin administration, not automatically the elimination half-life of circulating hexarelin itself.[2][1]
The study also fitted a dose-response model to estimate the maximum hormonal response. Its findings establish a human intravenous endocrine context for a synthetic hexapeptide. The library's stored timing scalar remains a tracking reference; the cited abstract does not resolve a separate subcutaneous hexarelin concentration-time profile.[2][1]
Cited amounts
The library records 5 mg as a supplier catalog package amount. This is the total listed in that presentation, not an amount selected for administration. No personal dosing range is inferred from it.[1][3]
Explore the Hexarelin dosing chartHalf-life and timing
Converting 0.92 hours gives 55.2 minutes. Three model intervals total 2.76 hours and leave 12.5%; five total 4.6 hours and leave 3.125%. The decimal values are exact consequences of the chosen scalar, not evidence that a person's concentration can be predicted to that precision. The source provides endocrine research context. This chart adds no absorption model, no measured individual starting concentration, and no rule for choosing the timing of another recorded amount.[1][5]
Explore the Hexarelin half-life modelReconstitution
A 5 mg total distributed across an assumed 2 mL would yield 2.5 mg/mL. For an alternative dimensional check, doubling the hypothetical volume to 4 mL gives 1.25 mg/mL. The total mass remains 5 mg in either equation. Showing both quotients makes clear what dilution arithmetic changes and what it preserves. Neither scenario is selected as a preparation instruction, and the catalog listing does not establish the clinical meaning of any portion calculated from it.[3]
Tracking it in PinPoint
From a reference to a record
Built for peptide, TRT, and GLP-1 schedules. Set up your vial in seconds, log every dose, and see your modeled levels between doses. Enter vial size in mg, mcg, or IU and water volume for instant concentration and syringe units. Track vials and prefilled pens side by side.[4]
The Home curve models your levels between doses from published half-life data. Drag to scrub modeled values at any timestamp, or preview 30 days of a dose pattern. Ask PinPoint provides educational reference with sources; it never recommends a dose or a schedule change. These features record and visualize entered information, with the limits of each compound's source data still applying.
Get PinPoint on the App StoreFrequently asked questions
- What does a hexarelin peptide calculator calculate?
- It converts a provided amount and concentration into volume. The 5 mg package reference comes from a supplier listing, while the 0.92-hour input belongs to the library's timing model. Neither value supplies an approved hexarelin dosing schedule.[1][2]
- Can hexarelin and ipamorelin share a calculator preset merely because both are secretagogues?
- Their records retain different identities and timing references. A matching package size would not make the molecules interchangeable. A concentration calculation may use the same formula, but its inputs still need to belong to the compound actually being recorded.[1][5]
- Why is the hexarelin chart endpoint 4.6 hours?
- It is five multiplied by the library's 0.92-hour input. The endpoint contains 3.125% of the starting model amount rather than zero. It is a calculated display position, not a source-backed personal clearance or administration time.[1][5]
- Can a peptide tracker app record Hexarelin?
- PinPoint's compound library includes Hexarelin. The app description covers logging compound, dose, site, and pain level, as well as viewing modeled levels between recorded doses. The curve uses published reference inputs and does not account for individual variation. The tracker records the schedule entered by its user; it does not choose a dose or recommend a schedule change.[1][4]
Sources
Facts and reference links were retrieved from the PinPoint application library on 5 October 2026. Links below preserve the library's citations; a catalog source supports a package amount only. Source references carried from the library have not all been independently reverified. Arithmetic examples are identified separately from clinical evidence.
- PinPoint compound library, HexarelinSnapshot of the application library; its references and uncertainty are retained below.Retrieved 2026-10-05 · library
- PubMed pharmacology reference 7957536Identity and research summary checked against this document on 5 October 2026. PubMed abstract, retrieved through NCBI EFetch.Retrieved 2026-10-05 · library-reference
- Supplier catalog package referencePackage amount only; not a clinical amount or endorsement.Retrieved 2026-10-05 · supplier
- PinPoint App Store descriptionFeature wording from the approved application description, not pricing.Retrieved 2026-10-05 · app-description
- Unit conversion and exponential-decay arithmeticC = amount / volume; remaining fraction = 2^(-elapsed / half-life). These are illustrations, not measurements.Retrieved 2026-10-05 · arithmetic